Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetically Modified T Cells in Treating Patients With Malignant Gliomas Overexpressing EGFR

NCT02331693 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT02331693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02331693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetically Modified T Cells in Treating Patients With Malignant Gliomas Overexpressing EGFR
Lead sponsor
RenJi Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
December 31, 2014
Completion date
December 31, 2016
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced glioma